MD News and Press, Mednax Inc. From 03/21/23

MONTREAL, March 21, 2023 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the commencement of a major exploration program for nickel in Nunavik, following up on exploration work carried out from 2020 to 2022 during which new Ni-Cu-Co mi...

Pediatrix Medical Group, Inc. (NYSE: MD) today announced that its board of directors has elected James D. Swift, M.D., the Company’s chief executive officer, as a director effective March 8, 2023. This appointment fills a seat previously held by Roger J. Medel, M.D. “Jim’...

MONTREAL, March 06, 2023 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland” or the “Corporation”) (TSX-V: MD) is pleased to report that it has completed a regional targeting study for lithium mineralization in the Eeyou Istchee James Bay region, which...

MONTREAL, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland’ or the “Corporation”) (TSX-V: MD) is pleased to announce the acquisition by map designation of 100% interest in an important strategic land position for its gold and lithium po...

Rising premature birth rate underscores the need for highly specialized, innovative neonatal care Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, babies and children, will host the top meeting in neonatal medici...

Pediatrix Medical Group, Inc. (MD) Q4 2022 Earnings Conference Call February 17, 2023 9:00 AM ET Company Participants Charles Lynch – Senior Vice President, Finance and Strategy Mark Ordan – Executive Chair Jim Swift – Chief Executive Officer M...

Pediatrix Medical Group press release ( NYSE: MD ): Q4 Non-GAAP EPS of $0.47 misses by $0.02 . Revenue of $514M (+3.0% Y/Y) beats by $12.03M . Adjusted EBITDA of $66M. On a preliminary basis, Pediatrix anticipates that its 2023 Adjusted EBITDA, as defined above, wi...

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.29 per share for the three months ended December 31, 2022. On a non-GAAP basis, Pediatrix repor...

Pediatrix Medical Group ( NYSE: MD ) is scheduled to announce Q4 earnings results on Friday, February 17th, before market open. The consensus EPS Estimate is $0.49 (-5.8% Y/Y) and the consensus Revenue Estimate is $501.97M (+0.6% Y/Y). Over the last 2 years, MD has beaten EP...

MONTREAL, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Midland Exploration Inc. ( “Midland” ) ( TSX-V: MD ) is pleased to provide an update on its drilling program totalling more than 10,000 metres on its gold and nickel-copper projects in the Abitibi region. This drilling program, dub...